MDMA has maintained its reputation as a party drug for some time, but psychiatrists are discovering that it is much more than that. The Multidisciplinary Association of Psychedelic Studies ( MAPS ) has just opened five clinical trials aimed at testing the effectiveness of MDMA in the treatment of PTSD. Until now, the results have been extremely positive.
People with serious PTSD can now submit their name for MDMA-assisted psychotherapy. Scientists are looking for participants in four states for the five clinical trials, the last phase before the US Food and Drug Administration could approve the substance for medical purposes.
The following five test sites are open to registration:
North Hollywood, California
Fort Collins, Colorado
New Orleans, Louisiana
Mount Pleasant, South Carolina
"If Phase 3 trials demonstrate significant efficacy and an acceptable safety profile, FDA approval is expected by 2021," according to MAPS. "Once approved, MDMA-assisted psychotherapy would only be available on prescription in therapeutic settings supervised by specially trained mental health care providers."
To see all the conditions, you have to fill in appropriate topics, go here.